20146 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
Pharmaceutical cyclosporin compositions
#302Reduction sensitive biodegradable polyesteramides
#303Method of treating endothelial dysfunction with oenothein B and proanthocyanidins
#304Oral pharmaceutical composition
#305Pharmaceutical compositions for inhalation
#306Early cancer detection and enhanced immunotherapy
#307System and method for delivering protease inhibitors
#308PHARMACEUTICAL ABUSE DETERRENT COMPOSITION
#309Skin external preparation and skin irritation-reducing method
#310Compositions for delivery of food allergens to the stomach
#311Method of administering amantadine prior to a sleep period
#312Calcitonin mimetics for treating diseases and disorders
#313Compositions comprising bacterial strains
#314Methods of manufacturing oral dosage forms
#315Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
#316SUSTAINED RELEASE BEADS AND SUSPENSIONS INCLUDING THE SAME FOR SUSTAINED DELIVERY OF ACTIVE INGREDIENTS
#317MESENCHYMAL STEM CELL-DERIVED EXOSOMES AND THEIR USES
#318Encapsulation
#319MICROCAPSULES COMPRISING A FAT-SOLUBLE ACTIVE SUBSTANCE
#320COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS
#321Homogenization system of drugs into biodegradable polymer: smart polymer system
#322Techniques and systems for treatment of neuropathic pain and other indications
#323Methods and compositions for muscular and neuromuscular diseases
#324Treatment and prevention of learning and memory disorders
#325Compositions and methods for treatment of osteoporosis and other indications
#326EXTENDED PRODUCTION OF NITRIC OXIDE FROM A MICROENCAPSULATED NITRITE SALT AND AN AQUEOUS ACIDIFIED GEL
#327BIOPHARMA APPLICATION OF MICELL TECHNOLOGY
#328Microcapsule formulation and method for producing the same
#329Stem cells having thin multilayer structure
#330Implantable medical devices having double walled microspheres
#331ANIMAL TISSUE COLONIZATION AND TREATMENT OF INFECTION
#332COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION-ASSOCIATED DISORDERS OF THE GASTROINTESTINAL TRACT
#333Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
#334RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERY
#335Microcapsules with polymeric coating comprising a lipid and an active agent
#336COMBINATION THERAPEUTIC NANOPARTICLES
#337Probiotic recolonisation therapy
#338Probiotic recolonisation therapy
#339Probiotic recolonisation therapy
#340Pharmacokinetics of S-adenosylmethionine formulations
#341Acyl nornicotines reduce sensory irritation in tobacco and nicotine products
#342High capacity diketopiperazine microparticles and methods
#343Peptide Pharmaceutical for Oral Delivery
#344Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using Same
#345ANTI-MICROBIAL AGENTS AND USES THEREFOR
#346ENCAPSULATED STEM CELLS FOR THE TREATMENT OF INFLAMMATORY DISEASE
#347Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation
#348COMPOSITIONS AND METHODS COMPRISING ENERGY ABSORBING COMPOUNDS FOR FOLLICULAR DELIVERY
#349Tamper-resistant dosage form with immediate release and resistance against solvent extraction
#350TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#351NOVEL ENCAPSULATION OF FLUORESCENT, PHOTO-SENSITIVE, OR OXYGEN-SENSITIVE ACTIVE INGREDIENT FOR TOPICAL APPLICATION
#352METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE
#353Probiotic recolonisation therapy
#354Probiotic recolonisation therapy
#355Method of treating inflammation
#356Formulations of viloxazine
#357Formulations useful in the treatment of proliferative diseases affecting the respiratory tract
#358Composition and methods of screening
#359Treating pain in patients with hepatic impairment
#360Liquid dosage forms of sodium naproxen
#361Formulations of viloxazine
#362Composition preventing necrotic enteritis in galloanserans
#363Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
#364Method of making particles for use in a pharmaceutical composition
#365Compositions, methods and devices for local drug delivery
#366Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diol
#367Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting
#368System and method for delivery of a protease inhibitor
#369Controlled release hydrocodone formulations
#370Method For The Therapeutic Treatment Of Keratinous Substrate, Mucous Membrane Or Tooth
#371Method for treating intestinal fibrosis
#372Reversible microcapsule filter cake
#373Compositions and methods for enhancing brain function
#374Methods for generating stem cell-derived β cells and uses thereof
#375Microcapsules containing an oxidizable active, and a process for preparing the same
#376METHODS FOR GENERATING AUGMENTED STEM CELL-DERIVED BETA CELLS AND USES THEREOF
#377METHODS FOR GENERATING STEM CELL-DERIVED BETA CELLS AND USES THEREOF
#378Antigenic compositions and methods
#379Pharmaceutical cyclosporin compositions
#380HYDROGEL DRUG DELIVERY IMPLANTS
#381RESEARCH BIO-NANOPARTICLE ELEMENTS AND PLATFORMS
#382Delayed Release Cysteamine Bead Formulation, And Methods Of Making And Using Same
#383Manufacture of Pharmaceutical Compositions
#384HIGH POTENCY PANCREATIN PHARMACEUTICAL COMPOSITIONS
#385Probiotic recolonisation therapy
#386Probiotic recolonisation therapy
#387Probiotic recolonisation therapy
#388Probiotic recolonisation therapy
#389Nucleic acid particles, methods and use thereof
#390MODIFIED RELEASE FORMULATION
#391Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
#392SOLID PHARMACEUTICAL DOSAGE FORM
#393Microspheres of pancreatic enzymes with high stability and production method thereof
#394INCREASED EFFECTIVENESS OF ALLYLAMINE DRUG COMPOUNDS FOR TOPICAL TREATMENT OF FUNGAL INFECTIONS OF THE SKIN AND SKIN APPENDAGES
#395Solvent system for enhancing the solubility of pharmaceutical agents
#396Oral pharmaceutical composition comprising taste-masked N-acetylcysteine
#397Methods for Treating or Preventing Migraines
#398Multistage delivery of active agents
#399Formulations
#400Techniques and systems for treatment of neuropathic pain and other indications
#401Compositions and methods for treatment of osteoporosis and other indications
#402Methods and compositions for muscular and neuromuscular diseases
#403Treatment and prevention of learning and memory disorders
#404COMBINATION THERAPEUTIC NANOPARTICLES
#405Particles containing a growth factor, and uses thereof
#406EXTENDED-RELEASE TOPIRAMATE CAPSULES
#407Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
#408Multiparticulate L-menthol formulations and related methods
#409METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING INTESTINAL INJURY AND DISEASES RELATED TO TIGHT JUNCTION DYSFUNCTION
#410Oral pharmaceutical composition
#411Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof
#412A METHOD FOR IMPROVING THE WELLBEING OF AN ANIMAL USING A COMPOSITION INCLUDING VITAMIN K
#413Method and compositions for genetic and retinal disease
#414COMPOSITIONS COMPRISING NON STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF
#415PRODUCT AND METHOD FOR TREATMENT OF A BIOFILM, INCLUDING CONTROL OF SUBSTRATE COLONIZATION AND TREATMENT OF INFECTION
#416Probiotic recolonisation therapy
#417COMPOSITIONS AND METHODS OF ENHANCING WEIGHT GAIN
#418Delayed release cysteamine bead formulation, and methods of making and using same
#419Preservatives
#420ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#421Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles
#422Probiotic recolonisation therapy
#423SOLID PHARMACEUTICAL PREPARATION CONTAINING LEVOTHYROXINE
#424Composition and method for aiding sleep
#425Controlled release hydrocodone formulations
#426Controlled release hydrocodone formulations
#427LAXATIVE COMPOSITIONS AND METHODS FOR TREATING CONSTIPATION AND RELATED GASTROINTESTINAL DISEASES AND CONDITIONS
#428Essential oil microparticles and uses thereof for preventing enteric diseases
#429COMPOSITIONS AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INFLAMMATORY BOWEL DISEASE
#430Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
#431Trans-Clomiphene Formulations and Uses Thereof
#432Process for making tablet using radiofrequency and lossy coated particles
#433NANOPARTICLE COMPOSITIONS
#434Multimodal antimicrobial therapy
#435Methods for enhancing the release and absorption of water insoluble active agents
#436Tamper-resistant oral opioid agonist formulations
#437Controlled release hydrocodone formulations
#438Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
#439FORMULATIONS AND USES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID DERIVATIVES FOR THE TREATMENT OF MALES
#440Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#441System and method for continuous polymer coating of particles
#442TREATMENT OF FISH POPULATIONS WITH LUFENURON
#443Pharmaceutical preparation and method for treatment of diabetes
#444Diamine oxidase for use in the treatment or prevention of attention deficit hyperactivity disorder (ADHD)
#445Pharmaceutical compositions for inhalation
#446Method of making particles for use in a pharmaceutical composition
#447Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails
#448Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
#449Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
#450Microsphere compositions, preparation method and applications thereof
#451MICROBUBBLE ULTRASOUND CONTRAST AGENT FOR EXTERNAL USE
#452PHARMACEUTICAL COMPOSITION COMPRISING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT
#453Treating pain in patients with hepatic impairment
#454Sustained Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers
#455Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
#456Techniques and systems for treatment of neuropathic pain and other indications
#457Compositions and methods for treatment of osteoporosis and other indications
#458Methods and compositions for muscular and neuromuscular diseases
#459Treatment and prevention of learning and memory disorders
#460Metal oxide particles aftertreated with organic phosphorus compounds
#461Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
#462Delayed release cysteamine bead formulation, and methods of making and using same
#463Multisomes: encapsulated droplet networks
#464Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
#465METHOD OF REDUCING SOMNOLENCE IN PATIENTS TREATED WITH TIZANIDINE
#466Compositions and methods for enhancing brain function
#467Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#468Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#469METHODS OF TREATING OBESITY IN RESPONDER AND NON-RESPONDER POPULATIONS
#470MICROENCAPSULATION OF OXYGEN LIBERATING REACTANTS
#471Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#472Colon lavage system
#473Compositions, methods, and devices for the treatment of eye stain
#474Method for treating intestinal fibrosis
#475Diaminooxidase-containing pharmaceutical compositions
#476Non-invasive in-situ radiation dosimetry
#477Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
#478SYSTEM AND METHOD FOR DIFFERENTIALLY TIMED LOCAL DELIVERY OF A COMBINATION PHARMACEUTICAL PREPARATION FOR ORAL THERAPY
#479Misuse preventative, controlled release formulation
#480Enteric delivery of functional ingredients suitable for hot comestible applications
#481Microorganism comprising particles and uses of same
#482Compositions comprising methylphenidate complexed with ion-exchange resin particles
#483Tamper-resistant oral opioid agonist formulations
#484CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#485Processing for dispersing amino acids
#486POLYMER MICROSPHERE COMPOSITIONS FOR LOCALIZED DELIVERY OF THERAPEUTIC AGENTS
#487Stabilized Protein Crystals, Formulations Containing Them and Methods of Making Them
#488Compositions and methods for treatment of osteoporosis and other indications
#489Methods and compositions for muscular and neuromuscular diseases
#490Techniques and systems for treatment of neuropathic pain and other indications
#491Treatment and prevention of learning and memory disorders
#492Treatment for bone formation disorders by growth factor delivery
#493CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#494Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders
#495Multiparticulate L-menthol formulations and related methods
#496Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles
#497Compositions comprising methylphenidate complexed with ion-exchange resin particles
#498DISINTEGRABLE CORE PARTICLE FOR PHARMACEUTICAL PREPARATION
#499Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#500CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITOR
#501Gamma hydroxybutyric acid granules
#502Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
#503Misuse preventative, controlled release formulation
#504PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY
#505Particles containing a growth factor, and uses thereof
#506Pharmaceutical cyclosporin compositions
#507Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
#508Methods for enhancing the release and absorption of water insoluble active agents
#509Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
#510COMPOSITIONS AND METHODS COMPRISING ENERGY ABSORBING COMPOUNDFS FOR FOLLICULAR DELIVERY
#511CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#512Crystalline anti-hTNFalpha antibodies
#513CLEAVABLE FUNCTIONALIZED NANOPARTICLES
#514MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#515Method for Treating Mammals for Uterine Disorders with Therapeutic Nanolipidic Vehicles
#516Anti-malaria compositions and methods
#517Controlled release dosage forms
#518FORMULATION OF LACOSAMIDE
#519Tamper-resistant oral opioid agonist formulations
#520Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles
#521ADJUVANT COMPOSITIONS AND METHODS OF POTENTIATING HDAC INHIBITORS USED TO TREAT VARIOUS DISEASES
#522Polymer nanocapsules entrapping metal nanoparticles
#523Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles
#524METHOD OF REDUCING SOMNOLENCE IN PATIENTS TREATED WITH TIZANIDINE
#525Amorphous medicinal fine particles produced by pulsed laser ablation in liquid and the production method thereof
#526Virion-like delivery particles for self-replicating RNA molecules
#527Methods and formulations for administration of resolvin anti-inflammatory compounds
#528Implantable medical devices having double walled microspheres
#529CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION
#530Anticoagulant-conjugated carbon nanocapsule, antithrombotic agent containing thereof
#531ENCAPSULATED PINK TOURMALINE FOR SKIN
#532SUSPENSION FORMULATIONS
#533Encapsulation device, medical capsules, and encapsulation method
#534Abuse-deterrent pharmaceutical compositions of opiods and other drugs
#535Compositions for reduction of side effects
#536Peptide pharmaceutical for oral delivery
#537Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof
#538MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#539Metal oxide particles aftertreated with organic phosphorus compounds
#540NANOPARTICLE COMPOSITIONS
#541Peptide pharmaceutical for oral delivery
#542Orally administrable pharmaceutical pellet of epidermal growth factor
#543Tamper-resistant oral opioid agonist formulations
#544SILICA PARTICLE INCLUDING A MOLECULE OF INTEREST, METHOD FOR PREPARING SAME AND USES THEREOF
#545Oral pharmaceutical composition
#546Crystalline anti-hTNFalpha antibodies
#547Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
#548Multiparticulate L-menthol formulations and related methods
#549Pharmaceutical compositions for the deterrence and/or prevention of abuse
#550Porous-wall hollow glass microspheres as carriers for biomolecules
#551MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#552Pharmaceutical Compositions
#553DRY POWDER COMPOSITION COMPRISING CO-JET MILLED PARTICLES FOR PULMONARY INHALATION
#554Compositions and methods for enhancing brain function
#555Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
#556Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
#557Peptide pharmaceutical for oral delivery
#558PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE 5 RECEPTOR (MGLU5) ANTAGONISTS
#559Resuscitation fluid
#560Resuscitation fluid
#561Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
#562METHOD OF REDUCING SOMNOLENCE IN PATIENTS TREATED WITH TIZANIDINE
#563Preparations facilitated by vesicles using alkyl polypentosides and uses of said preparations
#564Drug Delivery Catheters That Attach to Tissue and Methods for Their Use
#565METHOD OF TREATING CORONARY ARTERIES WITH PERIVASCULAR DELIVERY OF THERAPEUTIC AGENTS
#566Prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate
#567Controlled release hydrocodone formulations
#568Microorganism comprising particles and uses of same
#569MAGNETIC NANOMATERIALS AND METHODS FOR CHEMOEMBOLISATION
#570Melt-Coated Dosage Forms
#571Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#572Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#573Method of administering amantadine prior to a sleep period
#574Colon lavage system
#575Suspension formulations
#576PEGYLATED POLYPLEXES FOR POLYNUCLEOTIDE DELIVERY
#577Tamper-resistant oral opioid agonist formulations
#578Formulations comprising linaclotide
#579Methods for enhancing the release and absorption of water insoluble active agents
#580Pharmacokinetics of S-adenosylmethionine formulations
#581Microcapsules comprising a fat-soluble active substance
#582Diaminooxidase-containing pharmaceutical compositions
#583Sustained release beads and suspensions including the same for sustained delivery of active ingredients
#584Method for producing biologically ingestible material and biologically ingestible material obtained therefrom
#585Coated Pharmaceutical Compositions
#586Pharmaceutical composition of tacrolimus
#587Abuse-deterrent drug formulations
#588Stabilized protein crystals, formulations comprising them and methods of making them
#589Oral pharmaceutical composition
#590Microspheres
#591Methods and compositions for genetic and retinal disease
#592Laminated Microcapsule Sheet and Process For Production Thereof
#593Method of making particles for use in a pharmaceutical composition
#594Pharmaceutical cyclosporin compositions
#595Remedy
#596Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
#597Process for dispersing amino acids
#598Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration
#599TREATMENT FOR BONE FORMATION DISORDERS BY GROWTH FACTOR DELIVERY
#600Crystalline anti-hTNFalpha antibodies